Neurocare Technology · Bangalore, India
Innovating Protection. Enhancing Lives.
The compliance gap
in neurological safety
ends here.
70–80% of patients abandon traditional protective headgear within weeks. We built the solution they actually choose to wear — DazzleSafe™ — Safety Without Stigma. Among India's first CDSCO Class A registered soft protective helmet.
CDSCO Class A Registered
NABL Lab Verified
DPIIT Recognised Startup
Patent Pending
ICMR MedTech Mitra
88.1%
Impact Attenuation
139-147g
Ultra Lightweight
42+
Verified Users
0
Head Injuries Documented
DazzleSafe™ is for
Who We Serve
Three audiences.
One mission.
Whether you are a patient's family, a prescribing neurologist, or an investor in India's emerging MedTech sector — DazzleSafe™ was built for you.
01 / PATIENTS & CAREGIVERS
Protection that patients actually choose to wear.
For epilepsy, elderly fall risk, autism, and post-surgical recovery. Lightweight. Breathable. Dignified. Available on dazzlesafe.com and Amazon India.
Explore DazzleSafe™ →
02 / HEALTHCARE PROFESSIONALS
Prescribe with confidence. Backed by NABL lab testing & real-world outcomes.
CDSCO Class A registered. NABL-verified 88.1% impact attenuation. Full test reports available on request. Endorsed by Dr. Nirmal Surya, President, Epilepsy Foundation India.
Clinical Resources →
03 / INVESTORS & PARTNERS
India's first mover in a critically underserved MedTech category.
DPIIT-recognised startup. C-CAMP WIN CoE grant applicant (₹1 Crore / USD 100,000). $100K project roadmap. Series A target post-TRL 9. 12M epilepsy patients addressable in India alone.
Investor Overview →
Company Milestones
From idea to
registered MedTech.
In 18 months, Neurocare Technology has achieved what many startups take years to accomplish — regulatory registration, independent lab validation, patent filing, and real-world commercial adoption across 15+ Indian cities.
Full Company Story →2024Complete
Compliance Gap Identified
Research confirms 70–80% abandonment rate for existing protective headgear among neurological patients
Dec 2025Complete
NABL Accredited Lab Testing
Cotecna India confirms 88.1% impact attenuation, 483N strap retention, skin-safe pH 6.5–6.6 — Report CPSGGHD2534833
Mar 2026Complete
CDSCO Class A Registration
India's first soft protective helmet for epilepsy and fall risk registered as a Class A Medical Device. Reg. No. MFG/Class A-NSNM/2026/028112
Mar 2026Complete
DPIIT Startup Recognition
DIPP251123 — Healthcare & Life Sciences. Unlocks SISFS, NIDHI-SSP, and government R&D grant pathways
Apr 2026In Review
C-CAMP WIN CoE Grant Application
Wadhwani Foundation program — USD 100,000 (₹1 Crore) for clinical validation and CE MDR. Letter of Support received from C-CAMP BioNEST.
Q3 2026Upcoming
IEC-Approved Clinical Study
30-patient observational compliance study across leading neurology hospitals — formal validation pathway
Q4 2026Upcoming
CE MDR Class I Certification
EU regulatory approval unlocking 27-country European market and 3.4M epilepsy patients
What They Say
Trusted by doctors.
Loved by patients.
“
My sister has been saved multiple times from head injury during falls. She has been using the same unit for over 2 years and it has never failed her. First of its kind in India.
A
Ashrafunnisa
Caregiver · Epilepsy · Bangalore · 2+ years
Verified Purchase
“
It is lightweight and easy to wear. It is shielding my son from injuries during sudden and unpredictable falls. Now he can walk around at home and near premises without fear of head injuries.
S
Srinath · Father & Caregiver
Epilepsy patient's parent · Verified buyer · May 2026
Verified Purchase
WhatsApp Review
“
My 85-year-old mother wears it for long hours and is happy to wear it. The design is so much better than anything we tried before. Will definitely recommend it.
S
Shalmali
Caregiver · Elderly Fall Risk · Maharashtra
Verified Purchase